Expertise in
6
conditions

Dr. John A. Hovanesian

Ophthalmology
Harvard Eye Associates
Laguna Hills, CA 
Accepting New Patients
Expertise in
6
conditions
Harvard Eye Associates
Laguna Hills, CA 

Overview

John Hovanesian is an Ophthalmologist in Laguna Hills, California. Dr. Hovanesian is highly rated in 6 conditions, according to our data. His top areas of expertise are Cataract, Pterygium, Astigmatism, Dry Eye Syndrome, and Cataract Removal. Dr. Hovanesian is currently accepting new patients.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Ophthalmology

Licenses

Ophthalmology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Harvard Eye Associates
Laguna Hills, CA 92653
Other Locations
Harvard Eye Associates
Laguna Hills, CA 92653
Harvard Eye Associates
Laguna Hills, CA 92653
Harvard Eye Associates
1010 W. LA Veta Ave, Suite 175, Orange, CA 92868
Harvard Eye Associates
San Clemente, CA 92673
Harvard Eye Associates
Laguna Hills, CA 92653

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Clareon PanOptix Trifocal IOL: A Study of Patient Satisfaction and Visual Performance
The Clareon PanOptix Trifocal IOL: A Study of Patient Satisfaction and Visual Performance
Enrollment Status: Completed
Publish Date: March 15, 2023
Intervention Type: Device
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization-A Prospective Cohort Study of Combination Therapy in the Treatment of Dry Eye
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Phase: Phase 3
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Device
Study Phase: Not Applicable
The DEPOT Study (Dry Eye Prescription Options for Therapy): A Randomized Controlled Clinical Trial Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Eyelid Canaliculus in Comparison to Topical Loteprednol Suspension for the Treatment of Episodic Dry Eye
The DEPOT Study (Dry Eye Prescription Options for Therapy): A Randomized Controlled Clinical Trial Assessing the Efficacy and Safety of DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert, When Placed Within the Lower Eye Eyelid Canaliculus in Comparison to Topical Loteprednol Suspension for the Treatment of Episodic Dry Eye
Enrollment Status: Completed
Publish Date: January 03, 2022
Intervention Type: Drug
Study Phase: Phase 4
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
Enrollment Status: Completed
Publish Date: June 03, 2021
Intervention Type: Device
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
Enrollment Status: Completed
Publish Date: March 12, 2021
Intervention Type: Drug
Study Phase: Phase 4
The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery
The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery
Enrollment Status: Completed
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
Patient-Reported Satisfaction and Spectacle Independence With the ReSTOR 2.5 Combined With the ReSTOR 3.0 IOL in Cataract Surgery
Patient-Reported Satisfaction and Spectacle Independence With the ReSTOR 2.5 Combined With the ReSTOR 3.0 IOL in Cataract Surgery
Enrollment Status: Completed
Publish Date: June 05, 2019
Intervention Type: Device
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Enrollment Status: Terminated
Publish Date: October 12, 2018
Intervention Type: Drug
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Enrollment Status: Completed
Publish Date: March 07, 2017
Intervention Type: Drug
Study Phase: Not Applicable
View 10 Less Clinical Trials

48 Total Publications

The Unmet Need for Multiuse Phacoemulsification Machine Products: Multisociety Position Paper.
The Unmet Need for Multiuse Phacoemulsification Machine Products: Multisociety Position Paper.
Journal: Journal of cataract and refractive surgery
Published: October 01, 2025
Similar Doctors
Expertise in
19
conditions
Dr. Marjan Farid
Ophthalmology
Expertise in
19
conditions
Dr. Marjan Farid
Ophthalmology

Gavin Herbert Eye Institute

850 Health Sciences Rd, 
Irvine, CA 
 (18.3 miles away)
949-824-8600
Languages Spoken:
English
See accepted insurances

Marjan Farid is an Ophthalmologist in Irvine, California. Dr. Farid is highly rated in 19 conditions, according to our data. Her top areas of expertise are Astigmatism, Keratoconus, Hereditary Keratitis, Corneal Transplant, and Cataract Removal.

Expertise in
23
conditions
Dr. Baruch Kuppermann
Ophthalmology
Expertise in
23
conditions
Dr. Baruch Kuppermann
Ophthalmology

UCI Medical Center

101 The City Dr S, 
Orange, CA 
 (27.3 miles away)
714-456-7183
Languages Spoken:
English
See accepted insurances

Baruch Kuppermann is an Ophthalmologist in Orange, California. Dr. Kuppermann is highly rated in 23 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Vein Occlusion, and Vitrectomy.

Expertise in
26
conditions
Dr. David S. Boyer
Ophthalmology
Expertise in
26
conditions
Dr. David S. Boyer
Ophthalmology

Retina Vitreous Associates Medical Group

9001 Wilshire Blvd, 
Beverly Hills, CA 
 (60.8 miles away)
310-854-6201
Experience:
54+ years
Languages Spoken:
English
See accepted insurances

David Boyer is an Ophthalmologist in Beverly Hills, California. Dr. Boyer has been practicing medicine for over 54 years is highly rated in 26 conditions, according to our data. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Frequently Asked Questions about Dr. John A. Hovanesian

How do I make an appointment with Dr. John A. Hovanesian?

You can book an appointment with Dr. John A. Hovanesian by calling their office at 949-951-2020. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John A. Hovanesian a top-rated expert for Cataract?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John A. Hovanesian is classified as an Elite expert for Cataract, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John A. Hovanesian specialize in?

While Dr. John A. Hovanesian is a Ophthalmology, they have specific expertise in Cataract, Pterygium, and Cataract Removal. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. John A. Hovanesian participate in research or clinical trials?

Yes. Dr. John A. Hovanesian has published 48 articles and abstracts on conditions like Cataract. You can view a list of Dr. John A. Hovanesian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John A. Hovanesian accept my insurance?

Dr. John A. Hovanesian accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 949-951-2020 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hovanesian's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile